The effect of Bifidobacterium longum (4 ⍥ 10 8 viable cells/ g diet) and a derivative of inulin ('Raftiline HP'; 5% w/w in diet) on colonic aberrant crypt foci (ACF) induced by the colon carcinogen azoxymethane (AOM) has been studied. The concentration of ammonia, a putative tumour promoter produced by bacterial degradation of protein and urea, and the activities of certain bacterial enzymes thought to play a role in colon carcinogenesis, β-glucuronidase and β-glucosidase were also assayed. Consumption of either B.longum or inulin was associated with a decrease (26 and 41%, respectively) in AOM-induced small ACF (i.e. those comprising 1-3 aberrant crypts per focus). Combined administration of the bifidobacterium and inulin resulted in more potent inhibition of ACF than administration of the two separately, achieving 80% inhibition of small ACF. Furthermore, the combined administration significantly decreased the incidence (by 59%) of large ACF (>4 aberrant crypts per focus), which are considered to be predictive of eventual tumour incidence. Since the dietary treatments were started 1 week after the carcinogen dose, the results suggest that B.longum and inulin may be affecting the early promotion phase of the carcinogenic process. Consumption of diets containing B.longum, inulin or both were also associated with decreases in β-glucuronidase activity and ammonia concentration in the caecal contents. Both these factors have been associated with carcinogenesis of the colon in experimental animal models. In rats given inulin-containing diets (with or without B.longum) an increase in caecal wt and β-glucosidase activity and a decrease in caecal pH were observed. The results suggest that consumption of B.longum or inulin was associated with potentially beneficial changes in caecal physiology and bacterial metabolic activity in relation to tumour risk and in the incidence of putative preneoplastic lesions in the colon. The results also indicated that combined treatment with the two agents was more effective in reducing colonic lesions.
Introduction
The potential of yoghurt and other fermented milk products to confer health benefits on the consumer by increasing the number of lactic acid producing bacteria (LAB*) such as lactobacilli, bifidobacteria and streptococci in the intestinal tract is the subject of much current research. In particular, a possible role of dietary supplements of LAB in the prevention of cancer of the colon has received special attention. The term 'probiotic' has been adopted to describe such bacterial supplements that have beneficial effects on the consumer (1) . Supporting evidence for protective effects of probiotics against cancer has been obtained from in vitro experiments and studies in animals and in human volunteers. For example, LAB have been shown to prevent DNA damage and mutations in vitro (2) and to inhibit growth of tumour cells in culture (3, 4) . Oral administration to rats of strains of Lactobacillus and Bifidobacterium has been shown to inhibit DNA damage induced by N-methyl-N-nitro-N-nitrosoguanidine (MNNG), or 1,2-dimethylhydrazine (DMH), in the colon mucosa (5, 6) . In addition, feeding of Lactobacillus strains including L.acidophilus and Lactobacillus GG has been shown to decrease the incidence of preneoplastic lesions and tumours in the colons of rats challenged with 1,2-dimethylhydrazine (7, 8) . Similarly, in rats given Bifidobacterium longum, significant decreases were reported in the incidence of colon and liver tumours induced by 2-amino-3-methylimidazo [4,5f] quinoline (IQ) (9) . Studies on potential cancer preventing effects in human subjects are limited; however, consumption of lactobacilli by volunteers has been shown to reduce the mutagenicity of urine and faeces associated with the ingestion of carcinogens in cooked meat (10, 11) .
In the above rat carcinogenicity studies, it has been suggested that the decrease in carcinogen-induced tumour incidence was associated with the modification of gut bacterial activities related to the formation of carcinogens or tumour promoters in the gut (12, 13) . For example, the feeding to rats of L.acidophilus was associated with a decreased faecal activity of β-glucuronidase, azoreductase and nitroreductase (14) and was accompanied by a reduction in the incidence of DMHinduced colon carcinoma (7) .
The protective effects observed in the above studies are considered to be due to an increase in numbers of LAB in the large intestine. Such increases in colonic LAB can also be achieved by consumption of non-digestible oligosaccharides, which reach the colon and act as specific substrates for lactobacilli and bifidobacteria (12, (15) (16) (17) (18) (19) . The term 'prebiotic' has been coined to describe such substances (20) . We have recently demonstrated that lactulose, a synthetic, non-digestible disaccharide, decreases the degree of carcinogen-induced DNA damage in rat colon (21) .
Inulin is a component of several edible plants, including chicory, onion and garlic. It is a mixture of poorly digestible, fructose and glucose based, oligosaccharides that reach the colon and preferentially stimulate the growth of bifidobacteria in the gut (22, 23) . We have used a derivative of inulin, Raftiline HP, in which the low molecular wt mono-and disaccharide components (glucose, fructose and sucrose) have been removed, leaving a mixture of oligosaccharides with degree of polymerization of 3-60 (average [22] [23] [24] [25] .
The aim of the present study was to investigate the effect of B.longum and inulin administration on putative preneoplastic lesions (aberrant crypt foci; ACF) in the colonic mucosa of rats and on bacterial metabolic processes (β-glucuronidase, β-glucosidase and ammonia production) thought to be related to carcinogenesis. In addition, we aimed to determine whether combined administration of a Bifidobacterium strain and a carbohydrate source known to stimulate bifidobacterial numbers in the gut would increase the potency of any protective effects of the individual components. The term 'synbiotic' has been proposed to described potential additive or synergistic effects of pro-and prebiotics (20) . ACF are induced by treatment of rats with colon carcinogens and are considered to be early precursor lesions of colon tumours (24) (25) (26) . ACF lesions similar to those found in carcinogen-treated rodents have also been observed in colorectal cancer patients (26) . Several groups have used the formation of ACF as a predictive assay for the modulatory role of dietary components including LAB in colon carcinogenesis (27) (28) (29) (30) .
Materials and methods

Chemicals
Inulin (Raftiline HP) was purchased from Orafti s.a., Tienen, Belgium. Azoxymethane (AOM) was purchased from Sigma Chemical Company, Poole, Dorset, UK. All other chemicals, solvents and reagents used were of analytical grade.
Bacterial strain
Bifidobacterium longum 25 was provided by Unilever Research Laboratory (Vlaardingen). It was supplied as a freeze-dried powder in sealed packets containing~4ϫ10 10 colony forming units (c.f.u.)/g. The packets were kept at -20°C until used. Bifidobacteria in the diets were enumerated by serially diluting diet samples in brucella broth (Oxoid, Basingstoke, UK) and plating on to brain heart infusion supplemented (BHIs) agar containing, in 1 litre of deionized water: 37 g brain heart infusion broth (Oxoid), 5 g yeast extract (Oxoid), 4 ml resazurin solution (0.25 mg/ml), 0.5 g cysteine HCl, 10 ml hemin solution (0.5 mg/ml), 0.2 ml vitamin K solution (5 mg/ml) and 15 g Bacto agar (Difco Laboratories Ltd, West Molesey, Surrey). The diluting and plating procedures and incubation of the plates were carried out in an anaerobic cabinet (Don Whitley Scientific Ltd, West Yorkshire, UK) Plates were incubated for 5 days before colonies were counted. The colonies were all of similar morphology and comprised Gram-positive rods.
To confirm that B.longum could use inulin as a carbon source for growth, a general growth medium for LAB was used (MRS; 31) in which glucose was replaced by inulin (20 g/l), The growth medium (200 ml) was inoculated with 0.5 g of the freeze dried B.longum strain and incubated under static conditions at 37°C for 48 h. Afterwards, biomass concentrations were estimated with a spectrophotometer (660 nm; LKB Biochrom 4050, Cambridge, UK) with sterilized growth medium as a reference.
After incubation for 48 h, the culture was fully grown (to~3 g d.w./l) and microscopic observation showed typical Bifidobacterium structures. Based on these results, it was concluded that B.longum was capable of fermenting inulin.
Diets
Four diets were prepared : 1. Control diet, designated CO25 (Table I ). This was a purified diet containing starch, casein and corn oil (25% w/w). 2. Inulin diet. Inulin was added to the CO25 diet at a level of 5% (w/w). 3. B.longum diet. The freeze-dried B.longum preparation was incorporated into CO25 diet at a level of 1.7% w/w to provide~7ϫ10 8 c.f.u./g diet. 4 . B.longum/inulin diet. This contained inulin (5% w/w) and B.longum (1.7% w/w) in the CO25 basal diet. The diets were prepared every 2 weeks, and stored as 500-g portions at -20°C. The portions were thawed at room temperature immediately before use. Samples of each batch of the diets were taken for estimation of bifidobacteria content as described above. The rats were then transferred to CO25 diet. After a further week, all rats were dosed with azoxymethane (AOM) prepared in saline. Two doses of 12.5 mg/kg body wt, were given subcutaneously at 1 week apart. Three weeks after the transfer to CO25 (1 week after the second AOM dose), the rats were divided into four groups of 15, and fed the experimental diets as described above. Food intake was measured every 2 weeks. The rats were killed by cervical dislocation 12 weeks after the start of the experimental diets. The caecum was removed and the pH of the caecal contents determined in situ using a small pH probe. The contents were removed, weighed and frozen at -20°C for subsequent enzyme assays. The colons were removed, fixed and stained as described below.
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Assessment of aberrant crypt foci (ACF)
Colons (distal caecum to rectum) from the rats killed in the experiments were removed and slit longitudinally. Each colon was placed on a piece of white card, mucosal surface uppermost and the surface cleaned gently with 0.9% saline. The back of the card was sprayed with absolute ethanol and the card and its attached colon placed in 10% buffered formalin for at least 24 h for fixation of the tissue. The colons were then stained with 0.2% methylene blue in saline, to identify the foci of aberrant crypts (microadenomas) under a low power stereo microscope (24) . The number of ACF was determined, together with their distribution according to number of aberrant crypts per focus.
Measurement of β-glucuronidase and β-glucosidase activity in caecal contents
Samples of caecal contents from rats were homogenized in anaerobic 0.1 M potassium phosphate buffer, pH 7.2 to provide 10% (w/w) suspensions. The suspensions, in screw-cap bottles, were incubated anaerobically with p-nitrophenyl-β-D-glucuronide (3 mM) or p-nitrophenyl-β-D-glucopyranoside (3 mM) for assay of β-glucuronidase and β-glucosidase, respectively (32). Release of p-nitrophenol was measured colorimetrically over time and used as the measure of enzyme activity.
Measurement of caecal ammonia concentration
Samples of the 10% caecal homogenates were assayed for ammonia content using phenol nitroprusside and alkaline hypochlorite (33) . The blue colour that developed was measured spectrophotometrically at 570 nm, and the ammonia concentration calculated by reference to a standard curve of ammonium chloride determined concurrently.
Statistical analysis
Results were subjected to analysis of variance using the Minitab statistical package. Individual means were compared using the least significant difference criterion (34) .
Results
Food and bifidobacteria intake and body wt gain
The food intakes of the rats were similar in the four experimental diets, and ranged between 13.8 and 14.4 g/rat per day (P ϭ 0.60). The mean concentration of viable bifidobacteria in the experimental diets (B.longum and inulin/B.longum) was found to be 4.1ϫ10 8 c.f.u./g diet. Since the mean food intake of these two groups was 14.2 and 14.4, the bifidobacteria intake was 5.8 and 5.9ϫ10 9 c.f.u./rat per day, respectively. This represents a daily dose of~2ϫ1010 c.f.u./kg body wt per day for a 300-g rat. There were no significant differences between the dietary groups in the final body wt (420-430 g; P ϭ 0.86), or in body wt gain (285-293 g; P ϭ 0.90) of the rats during the experiment.
Caecal wt and caecal pH
Rats fed the diets containing 5% inulin or 5% inulin ϩ B.longum exhibited significantly increased (P Ͻ 0.001) caecal wts (25-32 % increase by comparison with rats fed the control diet) and significantly decreased (P Ͻ 0.001) caecal pH (Table  II) . Feeding B.longum without inulin did not increase caecal wt nor did it decrease pH of the caecal contents (Table II) .
Effect of B.longum and inulin on caecal ammonia and activity of β-glucuronidase and β-glucosidase in caecal contents
The concentration of ammonia in the caecal contents of the rats was significantly decreased (P Ͻ 0.01) by~25-30% by feeding inulin or B.longum, or both (Figure 1) . Similarly, the activity of the enzyme β-glucuronidase was significantly decreased in all the experimental groups in comparison with the rats fed the control diet (Figure 1) . The greatest decrease (P Ͻ 0.01) was seen in the rats fed inulin ϩ B.longum, in which the β-glucuronidase activity was~55% of that seen in the control rats (Figure 1) . Animals fed B.longum alone exhibited a smaller (30%), but nevertheless significant (P Ͻ 0.05) decrease in enzyme activity.
In contrast to the results for caecal ammonia and β-glucuronidase, the activity of the enzyme β-glucosidase in the caecum was increased in both groups of rats fed inulin, with those given the combination of bacteria and inulin exhibiting the most marked increase (~seven times the control value; Figure 1 ). Caecal β-glucosidase activity in the rats given B.longum alone was not significantly different from that of the control animals.
Effect of B.longum and inulin on ACF induction by AOM
In previous studies, no ACFs were detected in rats fed the same basal diet (CO25) that were not treated with a carcinogen (data not shown); consequently, no negative control animals were included in the present study. Treatment of rats with AOM induced ACF mainly in the distal half of the colon. The number of aberrant crypts per focus ranged from one to 14, although the majority of the ACF comprised one to three aberrant crypts (Figure 2 ). When incorporated into the CO25 diet, B.longum and inulin significantly decreased, by 29 and 21%, respectively, the total number of AOM-induced ACF (Figure 2 ). The decrease was most apparent in foci with 1-3 aberrant crypts, which were decreased by 41 and 26% by inulin and B.longum, respectively (Figure 2) .
The most potent inhibitory effect on AOM-induced ACF was seen in rats treated with the oligosaccharide-bacteria combination, which decreased total ACF numbers by 74% and ACF with 1-3 crypts per focus by 80% (Figure 2a and  b) . Numbers of the large ACF (those comprising four or Fig. 1 . Effect of B.longum and inulin on caecal β-glucuronidase and β-glucosidase activities and caecal ammonia concentration in rats. Rats were given AOM (2ϫ12.5 mg/kg, s.c.). At 1 week later the rats were fed CO25 diet (control), or CO25 with 5% inulin, or B.longum, or both for 12 weeks. The rats were then killed and caecal suspensions in buffer pH 7 were prepared, and enzyme activities and ammonia concentration measured. Enzyme activities are expressed as µmol product formed/h per g of caecal contents. Results are for six rats, bars show SEM. more aberrant crypts per focus) were significantly decreased (P Ͻ 0.05) by 59% in those rats fed the inulin/B.longum diet (Figure 2c ). In the animals treated with inulin or Fig. 2 . Effect of B.longum and inulin on AOM-induced ACF in rats. Rats were given AOM (2ϫ12.5 mg/kg, s.c.). At 1 week later the rats were fed CO25 diet (control), or CO25 with 5% inulin, or B.longum, or both for 12 weeks. The rats were then killed and colons removed, fixed, stained with methylene blue and ACF counted. Results are for 15 rats, bars show SEM. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001 in comparison with control value (ANOVA).
B.longum alone, no significant effects on numbers of large ACF were apparent (Figure 2c ). Numbers of very large ACF (10 or more aberrant crypts per focus) were low in all the animals, making statistical analysis of the data difficult. Nevertheless, all the dietary groups had lower numbers of these lesions (0.4, 0.2, 0.7 per colon) in the inulin, B.longum and inulin ϩ B.longum groups respectively) than in the control group (1.0 per colon), however, there were no statistically significant differences.
Discussion
The current study was designed to assess the potential cancerpreventing activity of a strain of LAB, B.longum, and a purified form of inulin specifically developed for food use. A further aim was to determine whether combined administration to rats of the B.longum, and the non-digestible oligosaccharide that stimulates bifidobacterial growth in the colon, results in more potent effects on development of the lesions and on gut bacterial metabolism and its products. The level of fat in the basal diet (44% of total energy) was designed to be comparable to that in the typical Western diet, which is associated with high risk of colon cancer (35) .
Inulin had a marked influence on both caecal wt and caecal pH, an effect reported previously after dietary administration of fermentable carbohydrates such as oligosaccharides (19) or dietary fibre (36) . B.longum administration alone did not affect these parameters.
Feeding B.longum or inulin decreased the incidence in the colon of ACF induced by AOM. Furthermore, combined treatment of rats with B.longum and inulin resulted in additive effects with levels of inhibition reaching 80%, providing good evidence for a 'synbiotic' effect. ACF are considered to be pre-neoplastic lesions, although their significance is the subject of debate. Some workers suggest that the number of larger ACF, with four or more aberrant crypts per focus, are more predictive of eventual tumour incidence than smaller ACF (1-3 aberrant crypts per focus). In the present study, the induction of small ACF was inhibited more strongly by B.longum or inulin than ACF with four or more crypts. However, the combination treatment strongly inhibited the larger ACF ( Figure 2 ) and the effect appeared to be synergistic rather than additive, since no inhibition of the large ACF was apparent in the groups fed inulin or B.longum alone.
Since the dietary treatments were started 1 week after the carcinogen dose, the results suggest that B.longum and inulin may be affecting the early promotion phase of the carcinogenic process. Taking these results in conjunction with those of previous studies (5, 6) , which indicate that bifidobacteria and lactobacilli inhibit DNA damage (considered to be associated with initiation events in carcinogenesis), it would appear that LAB can influence the carcinogenic process at more than one point, increasing their potential effectiveness as cancer preventing agents. Comparison of the metabolic measurements on the rats with the ACF data, suggest that caecal pH and β-glucosidase activity are not related to ACF induction since the pattern of response was not similar. They do, however, suggest that dietary inulin induced major changes in bacterial activity and possibly microflora composition. A decrease in pH of the luminal contents is considered to be a consequence of the increased bacterial production of short chain fatty acids and lactic acid in the gut (not measured in the present study), which have trophic effects on the gut mucosa (37) .
Oligosaccharides have previously been shown to increase β-glucosidase activity in the gut flora (19, 38) apparently due to the stimulation of numbers of LAB, which have high levels of β-glucosidase activity in comparison with other members of the gut microflora (38) . It could be concluded, therefore, that administration of B.longum alone does not increase bifidobacteria numbers in the gut sufficiently to stimulate β-glucosidase activity.
Activity of β-glucuronidase and caecal ammonia concentration appeared to follow a similar pattern to the inhibition of ACF. Despite its reported involvement in AOM metabolism (13) , it is unlikely that the changes in β-glucuronidase activity were causally related to the decreased incidence of ACF, since the dietary treatments were started 1 week after the last dose of carcinogen. In contrast, ammonia exhibits a number of effects on the colonic mucosa, including increasing mucosal cell turnover, which suggests that it may be involved in tumour promotion and has been shown to increase the incidence of colon carcinomas induced by MNNG in rats (39) . Consequently, the reduction in ammonia concentration may play a role in the protective effects of the dietary treatments on ACF induction.
